Bellevue Group’s Allergan plc AGN Stock Holding History

Bellevue Group’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-30,800	Closed	-$5.18M	–	230
2019 Q3	$5.18M	Sell	30,800 -1,300	-4%	-$212K	0.1%	108
2019 Q2	$5.38M	Buy	+32,100	New	+$4.44M	0.09%	106
2019 Q1	–	Sell	-16,000	Closed	-$2.14M	–	154
2018 Q4	$2.14M	Buy	16,000 +3,000	+23%	+$492K	0.14%	97
2018 Q3	$2.48M	Buy	13,000 +3,000	+30%	+$551K	0.16%	99
2018 Q2	$1.67M	Sell	10,000 -3,000	-23%	-$482K	0.14%	97
2018 Q1	$2.19M	Sell	13,000 -3,500	-21%	-$587K	0.22%	75
2017 Q4	$2.7M	Sell	16,500 -4,000	-20%	-$718K	0.28%	71
2017 Q3	$4.2M	Sell	20,500 -8,500	-29%	-$1.98M	0.44%	58
2017 Q2	$7.05M	Hold	29,000	–	–	0.83%	48
2017 Q1	$6.93M	Sell	29,000 -400	-1%	-$93.2K	0.92%	41
2016 Q4	$6.17M	Hold	29,400	–	–	1.26%	25
2016 Q3	$6.77M	Sell	29,400 -5,700	-16%	-$1.39M	1.22%	31
2016 Q2	$8.11M	Buy	+35,100	New	+$8.09M	1.53%	21

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bellevue Group's AGN Position: Q4 2019 in Review

Bellevue Group sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 30,800 shares — an estimated $5.18M sold.

Bellevue Group first reported a position in AGN in Q2 2016 and held it in 13 quarters. The position peaked at $8.11M in Q2 2016. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

Bellevue Group reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
Bellevue Group sold 30,800 Allergan plc shares in Q4 2019, an estimated $5.18M.
Bellevue Group first reported a position in Allergan plc in Q2 2016 and held it in 13 quarters.
Bellevue Group's Allergan plc position peaked at $8.11M in Q2 2016.
957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Bellevue Group's 13F filing for Q4 2019, filed 14 Feb 2020.